Natalizumab in cerebrospinal fluid and breastmilk of patients with multiple sclerosis

Natalizumab in cerebrospinal fluid and breastmilk of patients with multiple sclerosis

Background: Natalizumab is a highly effective monoclonal antibody for the treatment of multiple sclerosis (MS), which can diffuse in different anatomical compartments, including cerebrospinal fluid (CSF) and milk. Objectives: Starting from incidental detection of natalizumab in the CSF of MS patient...

Full description

Bibliographic Details
Main Authors: Ilaria Callegari, Mika Schneider, Vera Aebischer, Margarete M. Voortman, Undine Proschmann, Tjalf Ziemssen, Raija Lindberg, Bettina Fischer-Barnicol, Michael Khalil, Ludwig Kappos, Jens Kuhle, Nicholas S.R. Sanderson, Tobias Derfuss
Format: Article
Language:English
Published: SAGE Publishing 2023-01-01
Series:Therapeutic Advances in Neurological Disorders
Online Access:https://doi.org/10.1177/17562864221150040

Internet

https://doi.org/10.1177/17562864221150040

Similar Items